Chinese Pharmacopoeia (ChP)

The official compendium published by the Chinese Pharmacopoeia Commission sets quality standards for drugs, including their ingredients, manufacturing processes, and testing methods.

Similar to pharmacopeia in other countries, the ChP ensures consistency, safety, and efficacy of medications available in China.

Solutions you may be interested in

Entering the Chinese Market

Our in-house expert team assures your smooth market access in China. We provide a one-stop customized solution for regulatory strategy and filing, NMPA interaction, and other support

Regulatory Strategy

Design global patient-centric regulatory strategies to ensure expedited product development leading to patient access

Clinical Trials

Your trusted partner at every stage of clinical research, delivering tailored solutions through a collaborative and partnership-driven approach

Diverse team of professionals smiling, representing expert support at VCLS.

Questions? Get the answers from our expert team

No two product development paths are the same. Talk to our experts about your development challenges and we will provide you actionable recommendations.

Contact Us

Chinese Pharmacopoeia (ChP)

Chinese Pharmacopoeia (ChP)

RELATED INSIGHTS

How can you take advantage of China’s accelerated regulatory pathways for your product development?

New policy opens China biotechnology sector

Q&A regarding common concerns of China’s NMPA (National Medical Products Administration)

Solutions you may be interested in

Entering the Chinese Market

Regulatory Strategy​

Clinical Trials

Questions? Get the answers from our expert team ​

Regulatory Strategy

Questions? Get the answers from our expert team